American Society for Histocompatibility and Immunogenetics

EIN: 510173356 501(c)(3) Medical Research

Turnersville, NJ

Total Revenue
$3,200,681
Total Expenses
$2,914,665
Total Assets
$5,627,207
Net Assets
$4,662,672
🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Sign In — Free (10 views/day)

Financial Trends

Organization Details

Formation Year
1974
Legal Domicile
MO
Principal Officer
KATHERINE GIOVETSIS
Phone
8566380428
Tax Period
2024-01-01 to 2024-12-31

American Society for Histocompatibility and Immunogenetics, founded in 1974, is a community nonprofit in the Medical Research sector that reported $3.2M in total revenue in fiscal year 2024. Revenue grew 15% year-over-year, indicating healthy expansion. Expenses of $2.9M left a modest 9% surplus.

Mission

ADVANCING THE SCIENCE, EDUCATION & APPLICATION OF IMMUNOGENETICS & TRANSPLANT IMMUNOLOGY.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Sign In — Free (10 views/day)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $7,349
Program Service Revenue $2,615,398
Investment Income $546,041
Other Revenue $31,893
TOTAL REVENUE $3,200,681

Expense Breakdown

Grants Paid $96,769
Salaries & Benefits $846,689
Fundraising Expenses $0
Program Expenses $2,190,742
Other Expenses $1,971,207
TOTAL EXPENSES $2,914,665

Year-over-Year Comparison

2024 2023 Change
Revenue $3,200,681 $2,779,360 +0.2%
Expenses $2,914,665 $2,923,499 0.0%
Net Income $286,016 $-144,139 -3.0%
Key Indicators
✗ Grants to Organizations ✓ Grants to Individuals ✓ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required
🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Sign In

Governance

Voting Members
15
Independent Members
15
Employees
8
Volunteers
245

Governance Policies

✗ Conflict of Interest Policy
✗ Whistleblower Policy
✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School
✗ Operated a Hospital
✗ Provided First Class Travel
✗ Reported Conflict of Interest
✗ Reported Asset Diversion
✗ Excess Benefit Transaction
✗ Made Political Expenditures
✓ Engaged in Lobbying
✗ Operated Donor Advised Fund
✗ Maintained Art Collections
✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers
8
$168,714
Total Directors
17
$0
Key Employees
0
$0
Highest Compensated
2
reported
Name Title Hours/Week Role Reportable Comp Other Comp Total
KATHERINE GIOVETSIS CHIEF EXECUTIVE OFFICER 40.0
Officer
$168,714 $0 $168,714
MELISSA WEEKS ACCREDIDATION MANAGER 40.0
Highest
$129,854 $0 $129,854
MANDI CRUZ CHIEF OPERATING OFFICER 40.0
Highest
$121,264 $0 $121,264
LUIS G HIDALGO PHD SEE SCHEDULE O 3.0
Officer Director
$0 $0 $0
CATHI L MURPHEY PHD HCLDCC SEE SCHEDULE O 3.0
Officer Director
$0 $0 $0
ROBERT LIWSKI MD PHD PAST PRESIDENT (TIL 10/24) 3.0
Officer Director
$0 $0 $0
CAREY B KILLION BS MT CHS VICE PRESIDENT 3.0
Officer Director
$0 $0 $0
DOREEN SESE CHS SECRETARY 3.0
Officer Director
$0 $0 $0
LINDA BUCKERT MTASCP SBB CHS TREASURER (TIL 10/24) 3.0
Officer Director
$0 $0 $0
BRETT LOEHMANN CHS CHT TREASURER (EFF 11/24) 3.0
Officer Director
$0 $0 $0
JODY JENNEMANN BS MT ASCP CHS DIRECTOR 1.0
Director
$0 $0 $0
JANETTE KWOK MBBS PHD FRCPA FHK DIRECTOR 1.0
Director
$0 $0 $0
RACHEL WAHLERT MS CHSACHI DIRECTOR 1.0
Director
$0 $0 $0
KELLEY HITCHMAN MS PhD FACHI DIRECTOR 1.0
Director
$0 $0 $0
ANDRES JARAMILLO PHD DIRECTOR 1.0
Director
$0 $0 $0
RAJALINGAM RAJA PHD FACHI FRCP DIRECTOR 1.0
Director
$0 $0 $0
ERIC T WEIMER PHD DABMLI FAC DIRECTOR 1.0
Director
$0 $0 $0
ARIANNE MANKEY BS CHSACHI DIRECTOR 1.0
Director
$0 $0 $0
CAL STONE MS CHS DIRECTOR 1.0
Director
$0 $0 $0
REBECCA UPCHURCH MPA MLTASCPcm DIRECTOR 1.0
Director
$0 $0 $0
Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year Revenue Expenses Assets Net Income
2024 $3,200,681 $2,914,665 $5,627,207 $286,016
2023 $2,779,360 $2,923,499 $5,034,218 $-144,139
2022 $2,750,834 $3,018,443 $5,239,079 $-267,609
2021 $2,483,539 $2,539,453 $5,547,642 $-55,914
2020 $1,874,334 $1,976,626 $4,914,332 $-102,292
2019 $2,934,023 $2,835,095 $4,841,452 $98,928
2018 $2,620,397 $2,386,156 $4,032,279 $234,241
Explore More Nonprofits
→Top 100 Nonprofits in New Jersey →Largest U.S. Nonprofits →Best Rated Nonprofits →Most Efficient Nonprofits

Compare American Society for Histocompatibility and Immunogenetics with other nonprofits in New Jersey and across the country.

We Value Your Privacy
We use cookies and similar technologies to analyze site traffic and improve your experience. By clicking "Accept All", you consent to our use of cookies for analytics and measurement.